drugset / Trial / NCT04586361

Prospective Analysis of Introperative RegenLab PRP and Hyaluronic Acid in Patients With Knee ACL Tear

NCT04586361

Phase 4 Unknown 150 enrolled Kaohsiung Veterans General Hospital.
RandomizedParallel-groupSingle-blindTreatment

Summary

Purpose: The purpose of this article is to examine the clinical application of PRP and PRP+hyaluronic acid in disorders in the knee. Methods: The study was conducted on 150 adult patients with age over 20 years old affected by unilateral ACL complete tear and receiving ACL reconstruction. We divided the patients in three groups, and we treated the group A with perioperative injection of HHA, group B with perioperative HHA+PRP, group C with perioperative normal saline. Follow-up: Every 1,3,and 12months, we recheck physical exmianation at OPD and recheck MRI at postoperative 3 months.

Timeline

Start
2020-10-15
Primary completion
2021-09-15
Completion
2022-09-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Hyaluronic Acid Other / unclassified Other
Subject RegenLab PRP Unknown 1 unknown Other

Indications

No indication recorded.